Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells

International Journal of Cancer

Volumn 71, Issue 1, 1997, Pages 108-115

  Berger, Walter ^a,c   Hauptmann, Erich ^a   Elbling, Leonilla ^a   Vetterlein, Monika ^b   Kokoschka, Eva M ^c   Micksche, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZBROMARONE; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; MULTIDRUG RESISTANCE PROTEIN; N ETHYLMALEIMIDE; PROBENECID; PROTEIN; VINBLASTINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MELANOMA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BENZBROMARONE; BLOTTING, NORTHERN; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ETHYLMALEIMIDE; ETOPOSIDE; FEMALE; FLUORESCEINS; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROBENECID; RNA, MESSENGER; TUMOR CELLS, CULTURED; URICOSURIC AGENTS; VINBLASTINE;

EID: 0030932462     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970328)71:1<108::AID-IJC18>3.0.CO;2-E     Document Type: Article

References (25)

1. BELLAMY, W.T. and DALTON, W.S., Multidrug resistance in the laboratory and clinic. Adv. clin. Chem., 31, 1-6L (1994).
2. BERGER, W., ELBLING, L., MINAI-POUR, M., VETTERLEIN, M., PIRKER, R., KOKOSCHKA, E.M. and MICKSCHE, M., Intrinsic MDR-1 and P-glycoprotein expression in human malignant melanoma. Int. J. Cancer, 59, 717-723 (1994).
3. CAMPAIN, J.A., SLOVAK, M.L., SCHOENLEIN, P.V., POPESCU, N.C., GOTTESMAN, M.M. and PASTAN, I., Acquisition of multiple copies of a mutant topoisomerase II alpha allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines. Somat. cell. mol. Genet., 21, 451-471 (1995).
4. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWARD, A.J., KURZ, E.U., DUNCAN, A.M.V., and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992).
5. COLE, S.P.C., SPARKS, K.E., FRASER, K., LOE, D.W., GRANT, C.E., WILSON, G.M. and DEELEY, R.G., Pharmacological characterization of muitidrug resistant MRP- transfected human tumor cells. Cancer Res., 54, 5902-5910 (1994).
6. FELLER, N., BROXTERMAN, H.J., WÄHRER, D.C.R. and PINEDO, H.M., ATP-dependent efflux of calcein by the muitidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett., 368, 385-388 (1995).
7. FUTSCHER, B.W., ABBASZADEGAN, M.R., DOMANN, F. and DALTON, W.S., Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem. Pharmacol., 47, 1601-1606 (1994).
8. GEKELER, V., BECK, J., NOLLER, A., WILISCH, A., FRESE, G., NEUMANN, M., HANDGRETINGER, R., EHNINGER, G., PROBST, H. and NIETHAMMER, D., Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias. Ann. Hematol., 69, 19-24 (1994).
9. GUERRY, D.P. and SCHUCHTER, L.M., Disseminated melanoma - is there a new standard therapy? N. Engl. J. Med., 327, 560-561 (1992).
10. HINDENBURG, A.A., GERVASONI, J.E., KRISHNA, S., STEWARD, V.J., ROSADO, M., LUTZKY, J., BHALLA, K., BAKER, M.A. and TAUB, R.N., Intracellular distribution and pharmacokinetics of daunorubicin in anthracyclinesensitive and resistant HL-60 cells. Cancer Res., 49, 4607-4614 (1989).
11. HOLLO, Z., HOMOLYA, L., HEGEDÜS, T. and SARKADI, B., Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Lett., 383, 99-104 (1996).
12. IZOUIERDO, M.A., SHOEMAKER, R.H., FLENS, M.J., SCHEFFER, G.L., WU, L., PRATHER, R. and SCHEPER, R., Overlapping phenotypes of muitidrug resistance among panels of human cancer-cell lines. Int. J. Cancer. 65, 230-237(1996).
13. LEVINE, E.A., HOLZMAYER, T.A., RONINSON, I.B., and GUPTA, T.K.D., MDR-1 expression in metastatic malignant melanoma. J. surg. Res., 54, 621-624 (1993).
14. LOE, D.W., DEELEY, R.G., and COLE, S.P.C., Biology of the multidrug resistance-associated protein, MRP. Europ. J. Cancer, 32A, 945-957 (1996).
15. MARKS, R., An overview of skin cancers. Incidence and causation. Cancer, 75, 607-612 (1995).
16. MARSHALL, E.S., HOLDAWAY, K.M., SHAW, J.H.F., FINLAY, G.J., MATTHEWS, J.H.L. and BAGULEY, B.C., Amicancer drug sensitivity profiles of new and established melanoma cell lines. Oncol. Res., 5, 301-309 (1993).
17. NOOTER, K., and 14 OTHERS, Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res., 1, 1301-1310 (1995).
18. PROTA, G., D'Ischia, M. and MASCAGNA, D., Melanogenesis as a targeting strategy against metastatic melanoma: a reassessment. Melanoma Res., 4, 351-358 (1994).
19. SCHADENDORF, D., JURGOVSKY, K., KOHLMUS, C.M. and CZARNETZKI, B.M., Glutathione and related enzymes in tumor progression and metastases of human melanoma. J. invest. Dermatol., 105, 109-112 (1995a).
20. SCHADENDORF, D., MAKKI, A., STAHR, C., VAN DYCK, A., WANNER, R., SCHEFEER, G.L., FLENS, M.J., SCHEPER, R. and HENZ, B.M., Membrane transport proteins associated with drug resistance expressed in human melanoma. Amer. J. Pathol., 147, 1545-1552 (1995a).
21. SCHADENDORF, D., WORM, M., ALGERMISSEN, B., KOHLMUS, C.M. and CZARNETZKI, B.M., Chemosensitivity testing of human melanoma cells: retrospective analysis of clinical response and in vitro drus sensitivity. Cancer, 73, 103-108 (1994).
22. TWENTYMAN, P.R. and VERSANTVOORT, C.H.M., Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance. Europ. J. Cancer, 32A, 1002-1009 (1996).
23. TVEIT, K.M., GUNDERSEN, S., HOIE, J. and PIHL, A., Predictive ehemosensitivity testine in malignant melanoma: reliable methodology-ineffective drug's. Brit. J. Cancer, 58, 734-737 (1988).
24. USUI, N., MIMNAUGH, E.G. and SINHA, B.K., Synergistic antitumor activity of etoposide and human interleukin-1α against human melanoma cells. J. nat. Cancer Inst., 81, 1904-1909 (1989).
25. ZAMAN, G.J.R., VERSANTVOORT, C.H.M., SMIT, J.J.M., EIJDEMS, E.W.H.M., DE HAAS, M., SMITH, A.J., BROXTERMAN, H.J., MULDER, N.H., DE VRIES, E.G.E., BAAS, F., and BORST, P., Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res., 53, 1747-1750 (1993).